tiprankstipranks
Advertisement
Advertisement

HK:2096 Stock Latest News

Simcere Sets August 20 Board Meeting to Review Interim Results and Dividend Plan
Company AnnouncementsSimcere Sets August 20 Board Meeting to Review Interim Results and Dividend Plan
6d ago
2096
Simcere flags strong interim profit surge on innovative drug and licensing growth
PremiumCompany Announcements
Simcere flags strong interim profit surge on innovative drug and licensing growth
17d ago
2096
Simcere Stroke Drug SANBEXIN Added to China’s 2026 Essential Medicines List
PremiumCompany Announcements
Simcere Stroke Drug SANBEXIN Added to China’s 2026 Essential Medicines List
1M ago
2096
Simcere Shareholders Approve Dividend, Board Mandates at 2026 AGM
PremiumCompany Announcements
Simcere Shareholders Approve Dividend, Board Mandates at 2026 AGM
2M ago
2096
Simcere Declares Final Dividend for 2025 with July Payout to Shareholders
PremiumCompany Announcements
Simcere Declares Final Dividend for 2025 with July Payout to Shareholders
2M ago
2096
Simcere Wins NMPA Green Light for PD-1/VEGF Bispecific Cancer Therapy
PremiumCompany AnnouncementsSimcere Wins NMPA Green Light for PD-1/VEGF Bispecific Cancer Therapy
2M ago
2096
Simcere Secures Exclusive China Rights to PrimeGenX’s Pumecitinib Gel for Dermatology
Premium
Company Announcements
Simcere Secures Exclusive China Rights to PrimeGenX’s Pumecitinib Gel for Dermatology
3M ago
2096
Simcere sets June 2026 AGM to approve dividend, board re-elections and share issue mandate
Premium
Company Announcements
Simcere sets June 2026 AGM to approve dividend, board re-elections and share issue mandate
3M ago
2096
Simcere Wins NMPA Nod to Start Clinical Trials of Novel Oncology ADC SIM0613
PremiumCompany Announcements
Simcere Wins NMPA Nod to Start Clinical Trials of Novel Oncology ADC SIM0613
3M ago
2096
Simcere Wins NMPA Nod to Review Rademikibart NDA for Atopic Dermatitis
PremiumCompany Announcements
Simcere Wins NMPA Nod to Review Rademikibart NDA for Atopic Dermatitis
4M ago
2096
Simcere Withdraws and Plans to Resubmit NDA for Atopic Dermatitis Drug Rademikibart
PremiumCompany Announcements
Simcere Withdraws and Plans to Resubmit NDA for Atopic Dermatitis Drug Rademikibart
4M ago
2096
Simcere Grants 2.17 Million Performance-Tied RSUs to Employees Under 2021 Scheme
PremiumCompany Announcements
Simcere Grants 2.17 Million Performance-Tied RSUs to Employees Under 2021 Scheme
5M ago
2096
Simcere boosts 2025 profit 86% on surging innovative drug sales
PremiumCompany AnnouncementsSimcere boosts 2025 profit 86% on surging innovative drug sales
5M ago
2096
Simcere Pharmaceutical Proposes Final Dividend for 2025 Financial Year
Premium
Company Announcements
Simcere Pharmaceutical Proposes Final Dividend for 2025 Financial Year
5M ago
2096
Simcere Names New CEO, Backs Hire Despite Past Insider-Dealing Penalty
Premium
Company Announcements
Simcere Names New CEO, Backs Hire Despite Past Insider-Dealing Penalty
5M ago
2096
Simcere Pharma Moves to Modernize Articles, Enable Virtual Meetings and Treasury Shares
PremiumCompany Announcements
Simcere Pharma Moves to Modernize Articles, Enable Virtual Meetings and Treasury Shares
5M ago
2096
Simcere to Acquire Related Diagnostics Firm in RMB30.76 Million Connected Deal
PremiumCompany Announcements
Simcere to Acquire Related Diagnostics Firm in RMB30.76 Million Connected Deal
5M ago
2096
Simcere Pharma Reshapes Corporate Secretariat With New Joint Company Secretary
PremiumCompany Announcements
Simcere Pharma Reshapes Corporate Secretariat With New Joint Company Secretary
5M ago
2096
Simcere Showcases Promising Bladder Cancer Data for Novel Immunotherapy SIM0237
PremiumCompany Announcements
Simcere Showcases Promising Bladder Cancer Data for Novel Immunotherapy SIM0237
5M ago
2096
Simcere Schedules March Board Meeting to Approve 2025 Annual Results
PremiumCompany AnnouncementsSimcere Schedules March Board Meeting to Approve 2025 Annual Results
5M ago
2096
Simcere flags sharp profit jump and solid revenue growth for 2025
Premium
Company Announcements
Simcere flags sharp profit jump and solid revenue growth for 2025
6M ago
2096
Simcere Receives US$40 Million Milestone Payment From AbbVie for Multiple Myeloma Antibody SIM0500
Premium
Company Announcements
Simcere Receives US$40 Million Milestone Payment From AbbVie for Multiple Myeloma Antibody SIM0500
6M ago
2096

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >